Physician profile
Mark H Passarella
NPI 1841279445
$12,085.00
in general payments reported to CMS, 2019-2025
50 companies · $3,479 in 2025
The $3,479 reported for 2025 was more than what 88% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,115 · 2020: $494 · 2021: $1,108 · 2022: $1,645 · 2023: $1,701 · 2024: $2,543 · 2025: $3,479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,321 · Travel and Lodging: $1,302 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,320.79 |
| Travel and Lodging | $1,302.46 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,004.38 | 2020-2024 | Axonics, Bulkamid |
| Pfizer INC. | $1,238.20 | 2019-2025 | |
| Janssen Biotech, INC. | $1,075.45 | 2019-2025 | Erleada, Akeega, Rybrevant |
| Abbvie INC. | $827.89 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $735.18 | 2019-2025 | Provenge |
| Astellas Pharma US INC | $688.75 | 2019-2025 | Xtandi, Veozah |
| Boston Scientific Corporation | $681.56 | 2025 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $508.43 | 2023-2025 | Orgovyx, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $496.05 | 2019-2025 | |
| Palette Life Sciences, INC. | $434.80 | 2022 | |
| Dornier Medtech America, INC | $341.60 | 2023 | Dornier Medtech |
| Accord Healthcare, INC. | $330.31 | 2023-2025 | |
| Endo USA, INC. | $265.20 | 2024-2025 | Xiaflex, Aveed |
| Myovant Sciences INC. | $261.58 | 2021-2022 | |
| Immunitybio, INC. | $216.25 | 2025 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calyxo, INC. | $137.67 | 2025 | Cvac Aspiration System |
| Ferring Pharmaceuticals INC. | $137.65 | 2019-2025 | Adstiladrin |
| Blue Earth Diagnostics | $122.93 | 2021-2023 | |
| Antares Pharma, INC. | $118.32 | 2022-2024 | Xyosted, Nocdurna, Tlando |
| Travere Therapeutics, INC. | $110.39 | 2019 | |
| Medtronic, INC. | $94.40 | 2021-2025 | Altaviva |
| Merck Sharp & Dohme LLC | $91.63 | 2022-2023 | Lynparza, Keytruda, Welireg |
| Olympus America INC. | $82.49 | 2022-2025 | Uretero-Reno Videoscope, Hd Camera Head |
| Teleflex LLC | $79.95 | 2021-2025 | Barrigel |
| Myriad Genetic Laboratories, INC. | $78.22 | 2021-2024 | Prolaris |
| Progenics Pharmaceuticals, INC. | $72.30 | 2023-2025 | Pylarify |
| Abc Home Medical Supply, INC. | $70.84 | 2025 | |
| Urovant Sciences INC | $60.74 | 2021-2022 | |
| Allergan, INC. | $58.16 | 2019-2022 | |
| Medtronic USA, INC. | $55.07 | 2019-2020 | |
| Urogen Pharma, INC. | $52.91 | 2023-2025 | Jelmyto |
| Vertex Pharmaceuticals Incorporated | $46.64 | 2024-2025 | |
| Rochester Medical Corporation | $44.85 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $43.59 | 2019-2023 | Xiaflex, Aveed |
| Coloplast Corp | $40.45 | 2020-2025 | |
| Janssen Scientific Affairs, LLC | $39.13 | 2019 | |
| Sun Pharmaceutical Industries INC. | $34.39 | 2025 | |
| Photocure INC | $33.68 | 2024 | Cysview |
| Cycle Pharmaceuticals INC | $31.41 | 2025 | Venxxiva |
| Lantheus Medical Imaging, INC. | $31.19 | 2024 | |
| Neotract INC. | $28.95 | 2019 | |
| Amgen INC. | $27.61 | 2021 | |
| Novartis Pharmaceuticals Corporation | $23.66 | 2025 | |
| Ambu INC. | $22.67 | 2023 | |
| Profound Medical Corp. | $22.40 | 2025 | Tulsa-Pro |
| 180 Medical, INC. | $20.23 | 2019 | |
| Smith+Nephew, INC. | $18.30 | 2021 | |
| Dentsply Ih INC. | $16.03 | 2020 | |
| Karl Storz Endoscopy-America | $15.44 | 2021 | |
| Scpharmaceuticals INC. | $15.08 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Passarella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.